Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by BidaskClub

BidaskClub lowered shares of Simulations Plus (NASDAQ:SLP) from a buy rating to a hold rating in a report published on Thursday, February 15th.

Separately, Zacks Investment Research lowered Simulations Plus from a hold rating to a sell rating in a report on Thursday, December 14th.

Shares of Simulations Plus (NASDAQ SLP) traded up $0.10 during trading on Thursday, hitting $16.50. The stock had a trading volume of 33,800 shares, compared to its average volume of 52,021. Simulations Plus has a fifty-two week low of $9.45 and a fifty-two week high of $17.45. The stock has a market capitalization of $283.60, a P/E ratio of 45.56 and a beta of -0.74.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Tuesday, January 9th. The technology company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. Simulations Plus had a return on equity of 24.56% and a net margin of 23.78%. The firm had revenue of $7.07 million for the quarter, compared to analysts’ expectations of $6.57 million. research analysts anticipate that Simulations Plus will post 0.4 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Friday, January 26th were given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 1.45%. The ex-dividend date of this dividend was Thursday, January 25th. Simulations Plus’s dividend payout ratio is currently 68.57%.

In other Simulations Plus news, Chairman Walter S. Woltosz sold 18,500 shares of the stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $16.25, for a total transaction of $300,625.00. Following the sale, the chairman now directly owns 5,502,416 shares of the company’s stock, valued at approximately $89,414,260. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 55,500 shares of company stock worth $893,180 over the last ninety days. 33.45% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SLP. State Street Corp lifted its stake in Simulations Plus by 432.6% in the 2nd quarter. State Street Corp now owns 131,012 shares of the technology company’s stock worth $1,617,000 after purchasing an additional 106,412 shares in the last quarter. Northern Trust Corp raised its position in Simulations Plus by 248.7% in the second quarter. Northern Trust Corp now owns 145,018 shares of the technology company’s stock valued at $1,791,000 after purchasing an additional 103,435 shares during the period. Whalerock Point Partners LLC purchased a new stake in Simulations Plus in the fourth quarter valued at approximately $820,000. OxFORD Asset Management LLP raised its position in Simulations Plus by 471.6% in the third quarter. OxFORD Asset Management LLP now owns 58,336 shares of the technology company’s stock valued at $910,000 after purchasing an additional 48,131 shares during the period. Finally, Wedge Capital Management L L P NC purchased a new stake in Simulations Plus in the third quarter valued at approximately $730,000. 34.58% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by BidaskClub” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/23/simulations-plus-slp-downgraded-by-bidaskclub-to-hold.html.

Simulations Plus Company Profile

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply